Intrinsic Xenobiotic Resistance of the Intestinal Stem Cell Niche

Developmental Cell
Yuemin Celina CheeDavid M Virshup

Abstract

The gut absorbs dietary nutrients and provides a barrier to xenobiotics and microbiome metabolites. To cope with toxin exposures, the intestinal epithelium is one of the most rapidly proliferating tissues in the body. The stem cell niche supplies essential signaling factors including Wnt proteins secreted by subepithelial myofibroblasts. Unexpectedly, therapeutically effective doses of orally administered PORCN inhibitors that block all Wnt secretion do not affect intestinal homeostasis. We find that intestinal myofibroblasts are intrinsically resistant to multiple xenobiotics, including PORCN inhibitors and the anthracycline antibiotic doxorubicin. These myofibroblasts have high expression of a subset of drug transporters; knockout of Mrp1/Abcc1 enhances drug sensitivity. Tamoxifen administration to Rosa26CreERT2;mT/mG mice visually highlights the drug-resistant intestinal stromal compartment and identifies small populations of drug-resistant cells in lung, kidney, and pancreatic islets. Xenobiotic resistance of the Wnt-producing myofibroblasts can protect the intestinal stem cell niche in the face of an unpredictable environment.

Citations

Dec 4, 2019·Molecular Pharmacology·Zheng Zhong, David M Virshup
Sep 5, 2020·Nature Cell Biology·Neil McCarthyRamesh A Shivdasani
Feb 23, 2020·Frontiers in Cell and Developmental Biology·Emma H van Schie, Renée van Amerongen
Nov 19, 2020·Cancer Research·Nathan HarmstonBabita Madan
Mar 5, 2021·EMBO Molecular Medicine·Amanpreet KaurBabita Madan
May 18, 2021·The Journal of Biological Chemistry·Zhendong A ZhongBart O Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.